SCHEMBL1762650

SCHEMBL1762650

Cn1nc(C(F)F)c(C(N)=O)c1-c1ccccc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
GALR3 O60755 1/20 0.39
LMNA P02545 1/20 0.39
NR2F2 P24468 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD11B1 P28845 3/20 0.38
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
CNR1 P21554 5/20 0.37
KDM4E B2RXH2 2/20 0.37
MARS1 P56192 1/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1762661 0.91 HSD17B10 (0.38) KDM4ECYP1A2MAPTCYP2C9CYP2C19
SCHEMBL1762849 0.90 HSD17B10 (0.44) ALDH1A1LMNAHTTSMN1; SMN2HSD11B1
SCHEMBL1762833 0.85 PTGER4 (0.39) MAPTPTGER4
SCHEMBL3232405 0.84 CSNK1D (0.41) PKMHSD17B10PTGER4
SCHEMBL3325668 0.84 POLB (0.38) HSD11B1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL16972201 0.83 GRM2 (0.42) HSD11B1DPP4CNR1NPC1RAB9A
SCHEMBL18691186 0.82 POLB (0.35) DPP4HSD17B10GRM2
SCHEMBL3209298 0.82 HSD17B10 (0.38) HTTKDM4EMAPTHPGDRAB9A
SCHEMBL1762881 0.82 CSNK1D (0.41) ALDH1A1HTTSMN1; SMN2KDM4ENPC1
SCHEMBL1763226 0.81 CSNK1E (0.41) SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263327-B2 Enzymatic method for the production of microcapsules BASF SE (DE) 2012-09-11 US disclosed
US-20110124590-A1 Oil-in-Water Emulsion Comprising Solvent, Water, Surfactant and Pesticide BASF SE (DE) 2011-05-26 US disclosed
US-20100120617-A1 Enzymatic Method for the Production of Microcapsules BASF SE 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120617-A1 Enzymatic Method for the Production of Microcapsules MGAM, ACHE, BCHE ALDH1A1 989/4885GALR3 3078/4885LMNA 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.